| Document |
Document Title |
|
WO/2024/038980A1 |
The present invention relates to Lactobacillus plantarum KU15120 strain and a use thereof. The (Lactobacillus plantarum KU15120 strain was found to have antioxidative and anti-obese effects, which led to the present invention.
|
|
WO/2024/040001A1 |
Disclosed herein are genetically engineered yeast cells capable of producing ethanol. The genetically engineered yeast cells comprise an exogenous polynucleotide sequence encoding a glyceraldehyde-3-phosphate dehydrogenase (gapN) enzyme ...
|
|
WO/2024/039850A1 |
A method of producing fungal spores utilizing solid-state fermentation (SSF), the method including steps of combining, in a solid-state fermentation vessel, fungal spores and a solid substrate to produce a fungal culture; subjecting the ...
|
|
WO/2024/032012A1 |
Provided are a phenylalanine ammonia lyase mutant, an encoding gene thereof, a genetically engineered microorganism, and a method for preparing the phenylalanine ammonia lyase mutant. Also provided is use of the phenylalanine ammonia lya...
|
|
WO/2024/035661A1 |
This disclosure provides for an improved method of stabilizing spray-dried bacterial extracts with a composition comprising a stabilizer such that the extracts can be used in cell-free protein synthesis. Also provided herein are formulat...
|
|
WO/2024/032145A1 |
The present invention relates to the field of genetic engineering, and particularly, to a novel sterilization method for accurately and efficiently killing drug-resistant bacteria by means of the combination of CRISPR and a conjugated to...
|
|
WO/2024/032452A1 |
Provided is a Lactiplantibacillus plantarum 1-D1 strain and a use thereof. The strain features genetic stability, no pathogenic/virulent genes, good safety and strong antimicrobial ability to pathogenic microorganisms, and can reduce vag...
|
|
WO/2024/031508A1 |
The present invention relates to a method for detecting multiple target nucleic acids, and in particular, to a method for achieving rapid detection and simultaneous typing of various pathogenic microorganisms by utilizing digital magneti...
|
|
WO/2024/032512A1 |
The present invention relates to the technical field of reverse transcriptase mutants, and specifically, to a reverse transcriptase, a nucleic acid molecule, and a method for synthesizing a cDNA. By introducing mutations into the amino a...
|
|
WO/2024/032360A1 |
The present invention relates to the technical field of veterinary biological products, and specifically, to a lumpy skin disease virus strain, an inactivated vaccine prepared from the strain, and a method for preparing the vaccine. The ...
|
|
WO/2024/035336A1 |
The invention relates to a method of producing a Jasmonate using a fungal cell wherein the expression of the polyketide synthase (PKS) gene has been disrupted in the fungal cell. In one embodiment, the fungal cell is yeast cell Malassezi...
|
|
WO/2024/031835A1 |
Provided is use of Dendrobium officinale DoObgC and a variable spliceosome thereof in promoting embryonic axis elongation. The serial number of the Dendrobium officinale DoObgC nucleotide is KT359612.1. Also provided is a variable splice...
|
|
WO/2024/027697A1 |
Disclosed are encapsulated oncolytic virus genetic material and a use thereof. An embodiment specifically comprises a method for preparing lipid nanoparticles by encapsulating oncolytic virus genetic material, which comprises: preparing ...
|
|
WO/2024/028361A1 |
The present invention concerns a metabolically engineered microorganism for glycine bioproduction or a salt or an ester thereof, the genome of said microorganism comprises an attenuation of the expression of genes encoding enzymes having...
|
|
WO/2024/029662A1 |
The present invention relates to a method for mass producing highly pure neoagarotetraose (NA4) and neoagarohexaose (NA6) through substrate agarose liquefaction by using a thermostable GH16B β-agarase derived from a novel agar-degrading...
|
|
WO/2024/027798A1 |
The present invention provides a Pichia pastoris fermentation lysate filtrate, a preparation method therefor, and use thereof, and belongs to the technical field of cosmetic raw materials. Provided is a fermentation lysate filtrate prepa...
|
|
WO/2024/028385A1 |
The present invention relates to a genetically modified Methylobacteriaceae cell comprising at least one exogenous nucleic acid sequence encoding a glyoxylate reductase from the bacterium Escherichia, to a process for producing the genet...
|
|
WO/2024/029670A1 |
The present invention relates to a novel Lactobacillus sp. strain, a culture solution thereof and a body fat reduction composition comprising same, and, specifically, to: a novel Lactobacillus helveticus strain; a culture solution thereo...
|
|
WO/2024/026922A1 |
Provided are a method for simplifying the design, synthesis and assembly of a chloroplast genome of chlamydomonas reinhardtii, and use thereof. The method comprises: simplifying the design, total chemical synthesis, assembly, functional ...
|
|
WO/2024/029958A1 |
The present application relates to: a method for producing dead lactic acid bacteria cells, comprising a step of performing primary heat treatment and secondary heat treatment on any one or more lactic acid bacteria selected from the gro...
|
|
WO/2024/029976A1 |
The present invention relates to a strain of Pseudomonas fluorescens JNU01 (Accession number: KCTC14430BP) having plastic decomposition activity. The strain of Pseudomonas fluorescens JNU01 according to the present invention can decompos...
|
|
WO/2024/027251A1 |
Disclosed is a method for producing 7-hydroxybutylphthalide by means of fermentation of Penicillium vulpinum. In this method, an NCC3421 strain is used, formulas, process parameters, and the like of a shake flask seed culture solution, a...
|
|
WO/2024/022516A1 |
The present invention provides an anti-CD28 humanized single-domain antibody. Specifically, disclosed are a plurality of single-domain antibodies targeting CD28 and humanized antibodies thereof, derived proteins, gene sequences encoding ...
|
|
WO/2024/025094A1 |
The present invention relates to an antibacterial, antifungal, or antiseptic composition comprising a Paenibacillus elgi strain having antibacterial and antifungal activity, a culture medium or extract thereof, and a method for preparing...
|
|
WO/2024/024906A1 |
The present invention addresses the problem of providing a feature for promoting utilization of an oligosaccharide having a lacto-N-neotetraose skeleton in Bifidobacterium breve. The present invention provides a composition for promoting...
|
|
WO/2024/023259A1 |
The present invention relates to a compound of formula I, a stereoisomer, a tautomer and/or a dimer thereof or a salt thereof, (I) wherein M is a metal among the group of Mg, Cu and Zn; R1 is a methyl group or a formyl group; R2 is a car...
|
|
WO/2023/022662A9 |
Disclosed herein are cultures comprising Lactobacillus pobuzihii strains and uses thereof. Also disclosed herein are processes of fermentation, as well as soy sauce products, methods using the bacterial strains disclosed herein.
|
|
WO/2024/025101A1 |
The present invention pertains to (Saccharomyces cerevisiae) SPC Y76LT (KCTC 14767BP). The yeast strain (SPC Y76LT) of the present invention exhibits excellent fermentation efficiency across various sugar contents and thus can be applied...
|
|
WO/2024/021482A1 |
The present invention belongs to the field of microorganisms. Disclosed is bacillus coagulans capable of stably producing flavor substances of stinky tofu. According to the present invention, a bacillus coagulans strain is obtained from ...
|
|
WO/2024/022474A1 |
Provided is a chimeric transcriptional activator for a methanol-inducible promoter, which at least comprises a first portion and a second portion, wherein: 1) the first portion comprises: i) a DNA binding domain; or ii) a DNA binding dom...
|
|
WO/2024/025204A1 |
The present invention relates to antibacterial protein S2200 which has specific antibacterial activity against Staphylococci including Staphylococcus aureus. More specifically, the present invention relates to: antibacterial protein S220...
|
|
WO/2024/022036A1 |
Akkermansia muciniphila, which comprises one or both among AM06 and AM02. AM06 is Akkermansia muciniphila with an accession number of CGMCC No. 22793, and AM02 is Akkermansia muciniphila with an accession number of CGMCC No. 22794. It ha...
|
|
WO/2024/025207A1 |
The present invention relates to an antimicrobial protein SBL2200 having antimicrobial activity specific for Streptococci and, more specifically, to: a Streptococci-specific antimicrobial protein SBL2200 having the capacity to specifical...
|
|
WO/2024/025462A1 |
The invention relates to a method of modulating production of a metabolite in an actinomycetes bacterium comprising increasing the expression or activity of the Sporulation and Antibiotic Production Related gene A (SarA, SCO4069) polypep...
|
|
WO/2024/025209A1 |
The present invention relates to the antibacterial protein SBL200 with specific antibacterial activity against Streptococci. More specifically, the present invention concerns Streptococcus-specific antibacterial protein SBL200, and a com...
|
|
WO/2024/025206A1 |
The present invention relates to an antibacterial protein SSL200 having a specific antibacterial activity against Staphylococci including Staphylococcus aureus. More specifically, the present invention relates to: an antibacterial protei...
|
|
WO/2024/019354A1 |
The present invention relates to: a gene construct that enables, in an anticancer strain which is targeted to tumor sites and able to stimulate immune activity, the expression and secretion of a streptavidin (Stv)-fusion protein having t...
|
|
WO/2024/020364A1 |
Methods and systems to control continuous gas fermentation platforms for improved conversion of gas substrates into products is developed and particularly relates to a control process and system to control feedstock gases and maximize th...
|
|
WO/2024/019215A1 |
The present invention relates to a Corynebacterium sp. microbe with enhanced L-arginine or L-citrulline production capability and a method for producing L-arginine or L-citrulline by using same. The Corynebacterium sp. variant can improv...
|
|
WO/2024/017398A1 |
Provided are a new type of efficient flocculation denitrifying bacteria and the use thereof. Thauera sp. JM12B12 is separated and screened from water in a Penaeus vannamei culture pond, and was preserved in Guangdong Microbial Culture Co...
|
|
WO/2024/019355A1 |
The present invention relates to a gene construct characterized by encoding a fusion protein of flgM and strep-tag, wherein an anti-sigma factor flgM gene and a strep-tag-encoding gene are linked whereby the strep-tag can be expressed on...
|
|
WO/2024/019378A1 |
The present invention relates to a recombinant expression vector for conantokin-G secretion and an attenuated Salmonella strain transformed therewith, and provides: an attenuated Salmonella strain transformed with a recombinant expressio...
|
|
WO/2024/019377A1 |
The present invention relates to a recombinant expression vector for melittin secretion and an attenuated Salmonella strain transformed therewith, and provides an attenuated Salmonella strain transformed with a recombinant expression vec...
|
|
WO/2024/018061A1 |
Chronic obstructive pulmonary disease is a major clinical challenge mostly due to cigarette smoke exposure and affects more than 200 million people. The inventors tested if exposure to the Bordetella pertussis BPZE1 stain could modulate ...
|
|
WO/2024/012141A1 |
A feed additive rich in stachyose extract and Bacillus licheniformis, and a preparation method therefor. The method comprises: crushing Stachys japonica, Rehmanniae radix, and Stachys floridana to obtain a mixed dry powder, adding ethano...
|
|
WO/2024/013768A1 |
The present invention relates to a method of isolation of a novel avirulent FAdV4 strain which can be used as antigen for vaccine composition. The present invention also relates to the development of a vaccine composition comprising live...
|
|
WO/2024/014882A1 |
The present invention relates to: a Bacillus coagulans PA strain for producing a large amount of polyamine; and a polyamine preparation method using same. The Bacillus coagulans PA strain of the present invention proliferates in anaerobi...
|
|
WO/2024/011948A1 |
Provided are a high-efficiency levonorgestrel-degrading strain and the use thereof. The strain is Gordonia sp. H52 with the deposit number GDMCC No: 62995. The strain degrades levonorgestrel at a fast rate, can be used for degrading levo...
|
|
WO/2024/011666A1 |
A recombinant Escherichia coli modified by metabolic engineering means and a method for producing L-homoserine by using same. The strain is Escherichia coli having a strain number of 13-XA, and is deposited in China General Microbiologic...
|
|
WO/2024/012483A1 |
The present application relates to an attenuated African swine fever virus strain. Compared with a wild type genotype II African swine fever virus, the present attenuated African swine fever virus strain has the following gene fragments ...
|
